Histone deacetylase inhibitor treatment induces 'BRCAness' and synergistic lethality with PARP inhibitor and cisplatin against human triple negative breast cancer cells (Q34221822)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Histone deacetylase inhibitor treatment induces 'BRCAness' and synergistic lethality with PARP inhibitor and cisplatin against human triple negative breast cancer cells |
scientific article |
Statements
1 reference
Histone deacetylase inhibitor treatment induces 'BRCAness' and synergistic lethality with PARP inhibitor and cisplatin against human triple negative breast cancer cells (English)
1 reference
Kyungsoo Ha
1 reference
Warren Fiskus
1 reference
Dong Soon Choi
1 reference
Srividya Bhaskara
1 reference
Santhana G T Devaraj
1 reference
Bhavin Shah
1 reference
Sunil Sharma
1 reference
Jenny C Chang
1 reference
Ari M Melnick
1 reference
Scott Hiebert
1 reference
Kapil N Bhalla
1 reference
ImageQuant
2 references